Anti-PD-1 and PD-L1 antibodies in metastatic melanoma

Melanoma Manag. 2017 Dec;4(4):175-178. doi: 10.2217/mmt-2017-0018. Epub 2017 Nov 21.

Authors

Ester Simeone¹, Paolo A Ascierto¹

Affiliation

¹ Melanoma, Cancer Immunotherapy & Innovative Therapy Department at National Cancer Institute of Naples, Naples 80131, Italy.

No abstract available

Keywords: anti-PD-1 antibodies; metastatic melanoma; nivolumab; pembrolizumab.

Publication types

Editorial